Literature DB >> 21907921

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.

Ayumu Taguchi1, Katerina Politi, Sharon J Pitteri, William W Lockwood, Vitor M Faça, Karen Kelly-Spratt, Chee-Hong Wong, Qing Zhang, Alice Chin, Kwon-Sik Park, Gary Goodman, Adi F Gazdar, Julien Sage, Daniela M Dinulescu, Raju Kucherlapati, Ronald A Depinho, Christopher J Kemp, Harold E Varmus, Samir M Hanash.   

Abstract

We investigated the potential of in-depth quantitative proteomics to reveal plasma protein signatures that reflect lung tumor biology. We compared plasma protein profiles of four mouse models of lung cancer with profiles of models of pancreatic, ovarian, colon, prostate, and breast cancer and two models of inflammation. A protein signature for Titf1/Nkx2-1, a known lineage-survival oncogene in lung cancer, was found in plasmas of mouse models of lung adenocarcinoma. An EGFR signature was found in plasma of an EGFR mutant model, and a distinct plasma signature related to neuroendocrine development was uncovered in the small-cell lung cancer model. We demonstrate relevance to human lung cancer of the protein signatures identified on the basis of mouse models.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21907921      PMCID: PMC3406925          DOI: 10.1016/j.ccr.2011.08.007

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  55 in total

1.  Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer.

Authors:  Daniela M Dinulescu; Tan A Ince; Bradley J Quade; Sarah A Shafer; Denise Crowley; Tyler Jacks
Journal:  Nat Med       Date:  2004-12-26       Impact factor: 53.440

Review 2.  Screening and early detection of lung cancer.

Authors:  Susan C Van't Westeinde; Rob J van Klaveren
Journal:  Cancer J       Date:  2011 Jan-Feb       Impact factor: 3.360

3.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

4.  Small cell carcinomas of the lung express the Bcl-2 protein.

Authors:  J M Ben-Ezra; M J Kornstein; M M Grimes; G Krystal
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

Review 5.  Structure and function of the NPC2 protein.

Authors:  Marie T Vanier; Gilles Millat
Journal:  Biochim Biophys Acta       Date:  2004-10-11

6.  New serum markers for small-cell lung cancer. II. The neural cell adhesion molecule, NCAM.

Authors:  A Vangsted; L Drivsholm; E Andersen; E Bock
Journal:  Cancer Detect Prev       Date:  1994

7.  Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small-cell lung cancer (SCLC) with "limited" or "extensive" disease, and bone-marrow infiltration.

Authors:  J A Ledermann; F Pasini; Y Olabiran; G Pelosi
Journal:  Int J Cancer Suppl       Date:  1994

8.  Comprehensive proteome analysis of an Apc mouse model uncovers proteins associated with intestinal tumorigenesis.

Authors:  Kenneth E Hung; Vitor Faca; Kenneth Song; David A Sarracino; Larissa Georgeon Richard; Bryan Krastins; Sara Forrester; Andrew Porter; Alexandra Kunin; Umar Mahmood; Brian B Haab; Samir M Hanash; Raju Kucherlapati
Journal:  Cancer Prev Res (Phila)       Date:  2009-02-24

9.  Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration.

Authors:  Toshiyuki Murai; Yoshihiro Miyazaki; Hitomi Nishinakamura; Kazuki N Sugahara; Takayuki Miyauchi; Yasushi Sako; Toshio Yanagida; Masayuki Miyasaka
Journal:  J Biol Chem       Date:  2003-11-17       Impact factor: 5.157

10.  Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma.

Authors:  Y Lemos-González; F J Rodríguez-Berrocal; O J Cordero; C Gómez; M Páez de la Cadena
Journal:  Br J Cancer       Date:  2007-04-24       Impact factor: 7.640

View more
  82 in total

Review 1.  Integration of proteomics into systems biology of cancer.

Authors:  S Hanash; M Schliekelman; Q Zhang; A Taguchi
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2012-03-08

2.  Integrative Genomic Analyses Identifies GGA2 as a Cooperative Driver of EGFR-Mediated Lung Tumorigenesis.

Authors:  Hannah O'Farrell; Bryant Harbourne; Zimple Kurlawala; Yusuke Inoue; Amy L Nagelberg; Victor D Martinez; Daniel Lu; Min Hee Oh; Bradley P Coe; Kelsie L Thu; Romel Somwar; Stephen Lam; Wan L Lam; Arun M Unni; Levi Beverly; William W Lockwood
Journal:  J Thorac Oncol       Date:  2018-12-19       Impact factor: 15.609

Review 3.  Pleural involvement in lung cancer.

Authors:  Theodora Agalioti; Anastasios D Giannou; Georgios T Stathopoulos
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

4.  Proteomic Identification of Cysteine Cathepsin Substrates Shed from the Surface of Cancer Cells.

Authors:  Barbara Sobotič; Matej Vizovišek; Robert Vidmar; Petra Van Damme; Vasilena Gocheva; Johanna A Joyce; Kris Gevaert; Vito Turk; Boris Turk; Marko Fonović
Journal:  Mol Cell Proteomics       Date:  2015-06-16       Impact factor: 5.911

5.  A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening.

Authors:  William L Bigbee; Vanathi Gopalakrishnan; Joel L Weissfeld; David O Wilson; Sanja Dacic; Anna E Lokshin; Jill M Siegfried
Journal:  J Thorac Oncol       Date:  2012-04       Impact factor: 15.609

Review 6.  Unleashing the power of proteomics to develop blood-based cancer markers.

Authors:  Ayumu Taguchi; Samir M Hanash
Journal:  Clin Chem       Date:  2012-10-24       Impact factor: 8.327

7.  Multinozzle emitter array chips for small-volume proteomics.

Authors:  Pan Mao; Rafael Gomez-Sjoberg; Daojing Wang
Journal:  Anal Chem       Date:  2012-12-21       Impact factor: 6.986

8.  Imaging a functional tumorigenic biomarker in the transformed epithelium.

Authors:  Aaron M LeBeau; Minhee Lee; Stephanie T Murphy; Byron C Hann; Robert S Warren; Romelyn Delos Santos; John Kurhanewicz; Samir M Hanash; Henry F VanBrocklin; Charles S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

9.  Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B.

Authors:  William R Wikoff; Samir Hanash; Brian DeFelice; Suzanne Miyamoto; Matt Barnett; Yang Zhao; Gary Goodman; Ziding Feng; David Gandara; Oliver Fiehn; Ayumu Taguchi
Journal:  J Clin Oncol       Date:  2015-08-17       Impact factor: 44.544

10.  Chip-based nLC-TOF-MS is a highly stable technology for large-scale high-throughput analyses.

Authors:  L Renee Ruhaak; Sandra L Taylor; Suzanne Miyamoto; Karen Kelly; Gary S Leiserowitz; David Gandara; Carlito B Lebrilla; Kyoungmi Kim
Journal:  Anal Bioanal Chem       Date:  2013-03-23       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.